Investment & deals

  • US funding boost to lower barriers to sexual and reproductive care

    Women's digital health company Twentyeight Health has secures US$10m funding to expand its services in order to help lower barriers to sexual and reproductive care in the US. Twentyeight Health provides telemedicine consultations, at-home deliveries, and ongoing access to providers for services like birth control and herpes treatments, particularly in underserved communities. "45 per cent [...]

  • Persperity Health raises £1 million for sweat-sensing technology

    Persperity Health, a new company spun out of The California Institute of Technology, has raised $1 million in pre-seed funding to accelerate the development of its sweat-sensing technology that provides real-time, non-invasive hormonal insights. The technology enables real-time hormone monitoring through device-based sweat analysis, enabling non-invasive hormone monitoring for women ad providing personalised health insights. [...]

  • $1.9M grant will help protect newborns from necrotizing enterocolitis

    A University of Arizona College of Nursing-led research team will use a $1.9 million Department of Health and Human Services grant to lead a nationwide effort to keep babies safe from the deadly threat of necrotizing enterocolitis, known as NEC. According to the NEC Society, more than 3,500 babies are diagnosed with necrotizing enterocolitis in [...]

  • Breast cancer diagnostics AI startup raises US$2M in pre-series A funding

    Singaporean startup FathomX raised US$2M funding to develop its AI model for mammograms. FanthomX aims to increase the accuracy of mammograms in breast cancer detection using AI-integrated devices for detection, prevention and diagnostics.  Through this funding, the company will be able to harness the full potential of its digital AI solution to read medical images [...]

  • Global partnership to improve diagnostic accuracy of breast cancer

    A new partnership aims to advance AI-enabled digital pathology for end-to-end breast tumour profiling PathPresenter, a digital pathology platform and 4D Path, a Boston company producing computer-aided cancer diagnostic products, are announcing a global partnership to distribute 4D Q-plasia OncoReader Breast within the new clinical workflow platform, ClinPx. The 4D Q-plasia OncoReader Breast uses digitised [...]